2
|
Alphavirus-based vaccines. Viruses 2014; 6:2392-415. [PMID: 24937089 PMCID: PMC4074933 DOI: 10.3390/v6062392] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Revised: 06/03/2014] [Accepted: 06/04/2014] [Indexed: 12/18/2022] Open
Abstract
Alphavirus vectors have demonstrated high levels of transient heterologous gene expression both in vitro and in vivo and, therefore, possess attractive features for vaccine development. The most commonly used delivery vectors are based on three single-stranded encapsulated alphaviruses, namely Semliki Forest virus, Sindbis virus and Venezuelan equine encephalitis virus. Alphavirus vectors have been applied as replication-deficient recombinant viral particles and, more recently, as replication-proficient particles. Moreover, in vitro transcribed RNA, as well as layered DNA vectors have been applied for immunization. A large number of highly immunogenic viral structural proteins expressed from alphavirus vectors have elicited strong neutralizing antibody responses in multispecies animal models. Furthermore, immunization studies have demonstrated robust protection against challenges with lethal doses of virus in rodents and primates. Similarly, vaccination with alphavirus vectors expressing tumor antigens resulted in prophylactic protection against challenges with tumor-inducing cancerous cells. As certain alphaviruses, such as Chikungunya virus, have been associated with epidemics in animals and humans, attention has also been paid to the development of vaccines against alphaviruses themselves. Recent progress in alphavirus vector development and vaccine technology has allowed conducting clinical trials in humans.
Collapse
|
3
|
Lundstrom K. Alphaviruses in gene therapy. Viruses 2009; 1:13-25. [PMID: 21994535 PMCID: PMC3185459 DOI: 10.3390/v1010013] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2009] [Revised: 04/15/2009] [Accepted: 04/20/2009] [Indexed: 11/16/2022] Open
Abstract
Alphaviruses are enveloped single stranded RNA viruses, which as gene therapy vectors provide high-level transient gene expression. Semliki Forest virus (SFV), Sindbis virus (SIN) and Venezuelan Equine Encephalitis (VEE) virus have been engineered as efficient replication-deficient and -competent expression vectors. Alphavirus vectors have frequently been used as vehicles for tumor vaccine generation. Moreover, SFV and SIN vectors have been applied for intratumoral injections in animals implanted with tumor xenografts. SIN vectors have demonstrated natural tumor targeting, which might permit systemic vector administration. Another approach for systemic delivery of SFV has been to encapsulate replication-deficient viral particles in liposomes, which can provide passive targeting to tumors and allow repeated administration without host immune responses. This approach has demonstrated safe delivery of encapsulated SFV particles to melanoma and kidney carcinoma patients in a phase I trial. Finally, the prominent neurotropism of alphaviruses make them attractive for the treatment of CNS-related diseases.
Collapse
|
4
|
Zhang X, Hong L, Chan WY, Qiao T, Chen B, Liu Y, Fan D. Expression of MG7-Ag in patients with gastric cancer correlates with weaker T cell immune response and more proinflammatory cytokine secretion. Biochem Cell Biol 2006; 84:135-41. [PMID: 16609693 DOI: 10.1139/o05-174] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
MG7-Ag is a human gastric-carcinoma-associated antigen with a high specificity. So far it is remained unclear whether MG7-Ag is correlated with the in vivo cellular immune response of patients with gastric cancer. In this study, we detected the expression of the T cell receptor (TCR) repertoire of T cell subpopulations and cytokines in tumor-infiltrating lymphocytes (TIL), peripheral blood lymphocytes (PBL), and residue benign mucosal lymphocytes (NML) of patients with gastric cancer using semiquantitative RT-PCR. Our data showed that the expanded clones in CD8(+) NML and TIL and CD4+ NML and PBL in MG7-Ag-positive patients were significantly fewer than those of MG7-Ag-negative patients (p = 0.0360; p = 0.0026; p = 0.0065 p = 0.0109, respectively). The levels of IL-8 in CD8(+) TIL and TNF in CD4(+) TIL from the MG7-Ag-positive group were significantly higher than those from the MG7-Ag-negative group (p = 0.0302; p = 0.0177, respectively). Taken together, the results demonstrated a weaker T cell immune response and more proinflammatory cytokine secretion in MG7-Ag-positive patients with gastric cancer than in MG7-Ag-negative ones. This likely contributes to the poor prognosis in MG7-Ag-positive gastric-cancer patients.
Collapse
Affiliation(s)
- Xiaoyin Zhang
- State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, 4th Military Medical University, Xian, PR China
| | | | | | | | | | | | | |
Collapse
|
5
|
Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S, Katoh H. Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 2003; 89:1736-42. [PMID: 14583778 PMCID: PMC2394404 DOI: 10.1038/sj.bjc.6601331] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
To investigate the pathophysiological significance of infiltrating antitumour immune cells, we evaluated the quantity of immune cell intratumoral infiltration in 110 surgically resected gallbladder specimens by immunohistochemistry. We examined 45 cases of gallbladder cancer and 65 cases of benign gallbladder diseases for CD4+ T cells, CD8+ T cells, natural killer cells (NKCs), and dendritic cells (DCs). High levels of CD4+ T cell, CD8+ T cell, NKC, and DC infiltration were recognised in 51.1% (23 out of 45), 37.8% (17 out of 45), 33.3% (15 out of 45), and 48.9% (22 out of 45) of cancer specimens, respectively. High numbers of infiltrating CD4+ and CD8+ T cells correlated with decreasing tumour invasion, and high numbers of infiltrating DCs correlated with decreasing lymph-node tumour metastasis. Furthermore, increased infiltration of CD4+ and CD8+ T cells and DCs exhibited a significant correlation with prolonged survival. NKC infiltration, however, did not correlate with any of the clinicopathological factors examined. Additionally, high levels of infiltration were not identified in specimens from benign diseases, consistent with the cancer-specific activity of CD4+ and CD8+ T cells and DCs. In this study, we demonstrate that CD4+ and CD8+ tumour-infiltrating lymphocyte and DCs, but not NKCs, are important factors in the accurate prognosis of survival after surgical removal of gallbladder adenocarcinoma.
Collapse
Affiliation(s)
- Y Nakakubo
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - M Miyamoto
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan. E-mail:
| | - Y Cho
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - Y Hida
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - T Oshikiri
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - M Suzuoki
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - K Hiraoka
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - T Itoh
- Department of Pathology, Hokkaido University Hospital, N-14 W-5, Kita-ku, Sapporo 060-8648, Japan
| | - S Kondo
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| | - H Katoh
- Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, N-15 W-7, Kita-ku, Sapporo 060-8638, Japan
| |
Collapse
|